The Scene from China: VC and Tech Reach New Scale
At a Glance
In a significant shift for global venture capital, 2022 marked the first time that venture capital investment in China outpaced that of North America, a development underscored by Goldman Sachs' Piyush Mubayi who asserts that this growth signals a need for global investors to refine their perspectives on Chinese business models. Per the full note from Goldman Sachs, the influence of corporate venture capital in this realm is considerable as China's leading tech companies increasingly invest not only domestically but also target international markets. This seismic shift hints at a broader implication for currency dynamics, particularly as enthusiasm grows around the potential for these emerging business models to create opportunities in the FX space and impact USD/CNY valuations moving forward.
Key Takeaways
- 012022 saw China surpass North America in venture capital investment, a signal for global investors.
- 02Corporate venture capital in China is becoming a critical component of market strategies.
- 03The shift in investor sentiment may bolster the yuan against the dollar.
- 04This change in landscape presents new FX opportunities tied to Chinese business innovations.
Full Analysis
What the desk is arguing
The desk posits that China's rise in venture capital investment—surpassing North America—could trigger positive momentum for the yuan against the dollar. Added legitimacy to Chinese tech innovations may lead to a more favorable risk sentiment that enhances the CNY's position. Per the full note source, this shift indicates a broader acceptance and interest in Chinese ventures by global investors.
Supporting this narrative, China's impressive corporate venture capital involvement underscores a readiness to play a critical role in evolving markets. As of last year, Chinese investments not only surged ahead of those in North America but also reflected a growing domestic investor appetite—this could lead to a more diversified portfolio for investors looking at currency plays.
Where it sits in our coverage
Our current consensus for USD/CNY sits at 1.075, with a range spanning from 1.04 to 1.12. Specific firm targets to note include: - jpmorgan: 1.10 (Mar26) - bofa: 1.04 (Mar26)
This view aligns with jpmorgan, whose target reflects our desk's optimism, while it contrasts with bofa, suggesting a more cautious outlook at the lower end of our range. Given the upward revisions in sentiment around Chinese corporate ventures, the desk's call leans towards the bullish side of consensus forecasts.
How other firms see it
Among firms aligned with this view, jpmorgan sees a stronger yuan supported by China's tech sector boom while bofa holds a contrary stance, wary of potential economic headwinds. In particular, the divergence in views underscores the market's split perception of the economic recovery trajectory amid global uncertainties.
Such developments will likely have a notable influence on pairs like USD/JPY and EUR/USD, given these currencies also reflect broader investor sentiment towards Asian markets and risk appetite.
Market Implications
Traders should monitor USD/CNY closely as the yuan's strength could be supported by increased foreign interest in Chinese tech sectors, potentially pushing levels towards our upper forecast range of 1.10. Additionally, upcoming quarterly earnings reports from major Chinese tech firms could further illuminate this trend, especially if they reflect successful international expansions.
From the original
Last year, venture capital investment in China surpassed North American totals for the first time in history, bringing Chinese business models to a stage and scale that "the entire world needs to pay attention to" in the eyes of Goldman Sachs Research's Piyush Mubayi. Corporate v
Related speeches
4 itemsCloser Than You Think: What the Future Looks Like to Venture Capital
The desk argues that venture capital has become increasingly influential, with profound implications for global industries like healthcare and financial services. In the wake of notable successes from early stage investments, venture firms are pivoting towards innovative sectors, signaling an evolving investment landscape. Per the full note from Goldman Sachs, this shift offers insight into broader economic trends that could impact currencies linked to these industries. Market participants should note that while growth in venture capital is promising, it could lead to volatility as firms adjust their strategies.
"Scale, Sophistication and Global Relevance" -- Asia's Private Equity Market
The desk views the maturation of Asia's private equity market as a pivotal development that could influence global capital flows and currency positioning. Per the full note from Goldman Sachs, this growth, highlighted by unprecedented deal sizes and increased Chinese participation in global auctions, suggests a heightened sophistication within the region that investors must heed. This trend may immediately affect currency strategies, especially against the backdrop of stagnating opportunities in more established markets. As institutional players raise multi-billion dollar funds and seek opportunities in Asia, the implications for risk appetite and trade dynamics in FX markets could be significant.
Beneath Trade Clouds, China's Transition Opens Opportunities
Lead — Tim Moe from Goldman Sachs emphasizes the resilience of the Chinese economy amid rising trade tensions with the U.S., noting its shift towards a domestic consumption-driven growth model. He argues that despite the trade challenges, China's market liberalization represents a significant opportunity for global investors, particularly with the upcoming inclusion of China A shares in MSCI indexes. Per the full note [source], the value of these assets and their phased integration into global benchmarks necessitates preparedness from investors aiming to tap into a $9.3 trillion market. As this transition unfolds, positioning towards Chinese equities may bring unique alpha generation opportunities that traders must monitor closely.
From Pharmaceuticals to Medical Devices: What to Watch in China's Healthcare Sector
The desk emphasizes the growing potential of China's healthcare sector as a focal point for investment, noting that robust demand is spurred by an aging population and increased urbanization. Per the full note from Goldman Sachs, the healthcare industry is anticipated to experience substantial growth driven by shifts in consumer behavior and government investments. Concerns about risk-reward dynamics in this sector are paramount, particularly as the balance tilts towards emerging technologies in pharmaceuticals and medical devices. With no high-impact events on the immediate horizon, market participants should remain vigilant as these developments evolve.
More from GOLDMAN SACHS
5 items- GOLDMAN SACHS
What is Alternative Risk Premia and Why are Investors Excited About It?
- GOLDMAN SACHS
Is Womenomics Working?
- GOLDMAN SACHS
What's the Business Case for Investing in America's Low-Income Communities?
- GOLDMAN SACHS
Why Do Smaller Companies Receive Higher Valuations for New Initiatives?
- GOLDMAN SACHS
What's Keeping Insurers Up at Night?